DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Taurolidine
Taurolidine
Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning
Taurosept®
Minimising Blood Stream Infection: Developing New Materials for Intravascular Catheters
ESCMID Online Lecture Library © by Author
Rxoutlook® 1St Quarter 2019
Chronic Pulmonary Aspergillosis: Rationale and Clinical Guidelines for Diagnosis and Management
Rxoutlook® 4Th Quarter 2020
Progress in the Pharmacological Treatment of Human Cystic and Alveolar Echinococcosis: Compounds and Therapeutic Targets
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
2 Soluble Polyvinylpyrrolidone (Povidone)
Varlabelxref 6.6.1
Contribution of Anti-Inflammatory and Anti-Virulence Effects of Azithromycin (AZM) in Ocular Surface Infection Treatment
(12) United States Patent (10) Patent No.: US 9,012.437 B2 Wong Et Al
Synergistic Apoptotic Effects of Taurolidine and TRAIL on Squamous Carcinoma Cells of the Esophagus
Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia
Clinical Outcomes of Home Parenteral Nutrition Patients Using Taurolidine As Catheter Lock: a Long-Term Cohort Study
Tepzz¥Z979z¥A T
Current Strategies for the Prevention and Management of Central Line-Associated Bloodstream Infections Zhuolin Han Washington University School of Medicine in St
Top View
Ep 0253662 A1
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Efficacy of Taurolidine Against Periodontopathic Species—An in Vitro Study
Orphan Drug Designation List
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Taurolidine-Based Catheter Lock Regimen Significantly
Ep 0253662 B1
Promising Drug Candidates and New Strategies for Fighting Against the Emerging Superbug Candida Auris
Methods for Preventing Central Line Associated Bloodstream Infection in Pediatric Hematology-Oncology Patients: a Systematic Literature Review, 2010-2020
WO 2U11/132171 Al
Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition
As) United States A2) Patent Application Publication Co) Pub. No.: US 2015/0313221 Al Piotrowski Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
Rxoutlook® 1St Quarter 2021
(12) Patent Application Publication (10) Pub. No.: US 2015/0335707 A1 Swamynathan Et Al
Harmonized Tariff Schedule of the United States (2006) (Rev
(12) United States Patent (10) Patent No.: US 6,331,289 B1 Klaveness Et Al
Taurolidine-Citrate-Heparin Lock Reduces Catheter-Related
(12) Patent Application Publication (10) Pub. No.: US 2010/0087788 A1 Rosenblatt Et Al
Antibiotic Treatment for Cystic Fibrosis the Grading Scheme, Used in These Guidelines Is As Recommended by the Scottish Intercollegiate Guidelines Network (SIGN)
FIXED DOSE COMBINATIONS APPROVED by DCG (I) SINCE 1961 TILL 12Th July 2018
CLINICAL GUIDELINES Care of Adults with Cystic Fibrosis 2013
FIXED DOSE COMBINATIONS APPROVED by DCG (I) SINCE 1961 to 28Th JUNE 2019
The Clinical Spectrum of Pulmonary Aspergillosis Chris Kosmidis, David W Denning
Taurolidine Sensitivity of Eryptosis, the Suicidal Erythrocyte Death
WO 2009/092601 Al
"Antimicrobial Materials: - a Clinician's Perspective"